- Conditions
- SARS-CoV2 Infection
- Interventions
- Remdesivir
- Drug
- Lead sponsor
- Gilead Sciences
- Industry
- Eligibility
- 12 Years and older
- U.S. locations
- 165
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fresno, California + 130 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
Recognized from query: expanded access. Matching terms were moved into the structured fields above when recognized.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 485
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Parenteral Nutrition-Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Cook Children's Health Care System
- Other
- Eligibility
- 4 Weeks to 5 Years
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Lucanix® (belagenpumatucel-L)
- Biological
- Lead sponsor
- NovaRx Corporation
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Neuroendocrine Tumors
- Interventions
- 68Ga-DOTATOC PET/CT Scan
- Drug
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 5 Years and older
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Metachromatic Leukodystrophy
- Interventions
- Enriched Hematopoetic Stem Cell Infusion
- Biological
- Lead sponsor
- Talaris Therapeutics Inc.
- Industry
- Eligibility
- Female only
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Peanut Allergy
- Interventions
- DBV712 250 mcg
- Combination Product
- Lead sponsor
- DBV Technologies
- Industry
- Eligibility
- 2 Years to 17 Years
- U.S. locations
- 1
- States / cities
- Madison, Connecticut
- Conditions
- Atrial Fibrillation
- Interventions
- Lovaza (Fish Oils)
- Drug
- Lead sponsor
- St. Luke's-Roosevelt Hospital Center
- Other
- Eligibility
- 18 Years and older
- U.S. locations
- 3
- States / cities
- Ridgewood, New Jersey • New York, New York
- Conditions
- Acromegaly
- Interventions
- Pasireotide long acting release formulation
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 37
- States / cities
- Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 30 more
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Donislecel (allogeneic islets of Langerhans for transplant)
- Biological
- Lead sponsor
- CellTrans Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
- Interventions
- Busulfan, Cytarabine, Fludarabine phosphate, mycophenolate mofetil, tacrolimus, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation
- Drug · Procedure · Radiation
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Other
- Eligibility
- Up to 69 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2015
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Mesothelioma
- Interventions
- Pemetrexed, Cisplatin
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Basking Ridge, New Jersey
- Conditions
- Prostate Cancer
- Interventions
- F18-DCFPyL, Gadolinium, Positron emission tomography (PET)/Magnetic Resonance Imaging (MRI) Scan
- Drug · Procedure
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older · Male only
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- HIV Infections
- Interventions
- Atazanavir (BMS-232632)
- Drug
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- 16 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2003
- U.S. locations
- 163
- States / cities
- Hobson City, Alabama • Anchorage, Alaska • Phoenix, Arizona + 158 more
- Conditions
- COVID, Sars-CoV2, Corona Virus Infection
- Interventions
- Convalescent Plasma
- Biological
- Lead sponsor
- Jonathan Gerber
- Other
- Eligibility
- 12 Years and older
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
- Conditions
- Peripheral Arterial Disease, Peripheral Vascular Diseases, Critical Limb Ischemia
- Interventions
- Bone marrow concentration device
- Device
- Lead sponsor
- Zimmer Biomet
- Industry
- Eligibility
- 21 Years and older
- U.S. locations
- 9
- States / cities
- Little Rock, Arkansas • Atlanta, Georgia • Indianapolis, Indiana + 5 more
- Conditions
- Aortic Aneurysm, Penetrating Ulcer, Vascular Disease
- Interventions
- Zenith TX2 Low Profile TAA Endovascular Graft
- Device
- Lead sponsor
- Cook Group Incorporated
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 15
- States / cities
- Tampa, Florida • Atlanta, Georgia • Indianapolis, Indiana + 11 more
- Conditions
- Neuroblastoma, Pheochromocytoma
- Interventions
- 131-I-meta-iodobenzylguanidine
- Drug
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 365 Days to 29 Years
- U.S. locations
- 1
- States / cities
- New Hyde Park, New York
- Conditions
- Critical COVID-19 With Respiratory Failure
- Interventions
- ZYESAMI (aviptadil acetate)
- Drug
- Lead sponsor
- APR Applied Pharma Research s.a.
- Other
- Eligibility
- 12 Years to 100 Years
- U.S. locations
- 25
- States / cities
- Gilbert, Arizona • Scottsdale, Arizona • Baldwin Park, California + 20 more
- Conditions
- Phenylketonuria
- Interventions
- Sapropterin dihydrochloride
- Drug
- Lead sponsor
- BioMarin Pharmaceutical
- Industry
- Eligibility
- 9 Years and older
- U.S. locations
- 36
- States / cities
- Los Angeles, California • Orange, California • San Diego, California + 33 more
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, PALS
- Interventions
- CNM-Au8
- Drug
- Lead sponsor
- Clene Nanomedicine
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 8
- States / cities
- Fort Lauderdale, Florida • Chicago, Illinois • Iowa City, Iowa + 4 more
- Conditions
- EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer
- Interventions
- Datopotamab deruxtecan
- Drug
- Lead sponsor
- Daiichi Sankyo
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 14
- States / cities
- Springdale, Arkansas • Honolulu, Hawaii • Bowling Green, Kentucky + 10 more
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Trehalose
- Drug
- Lead sponsor
- Seelos Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 21
- States / cities
- Phoenix, Arizona • Orange, California • San Francisco, California + 16 more
- Conditions
- Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
- Interventions
- Lorlatinib
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 49
- States / cities
- Sedona, Arizona • Huntington Beach, California • Irvine, California + 30 more
- Conditions
- Crohn's Disease, Ulcerative Colitis
- Interventions
- Vedolizumab IV
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 2 Years and older
- U.S. locations
- 3
- States / cities
- San Francisco, California • Atlanta, Georgia • Seattle, Washington